2q 15 vcsurvey

Page 1

Venture Capital Funding Survey, Second Quarter 2015

VENTURE CAPITAL FUNDING, SECOND QUARTER 2015 This is a listing of many of the Bay Area firms that received venture capital financing between June 30 and Aug. 31, 2015. Most of the data was compiled from a survey conducted by PricewaterhouseCoopers, Thomson Venture Economics and the National Venture Capital Association in conjunction with the Mercury News. In the case of some investments there may have been other participants in the round who are not credited. Also, the amounts listed may not include all venture funding the company received during the quarter. *Indicates this is a seed or first-round infusion of money from venture capitalists. These companies may have received money previously from other investors and aren't necessarily start-ups. BIOTECHNOLOGY / HEALTH Name

Aduro BioTech

City

Berkeley

Advanced Cell Diagnostics Hayward

Aegea Medical

Autonomic Technologies

Redwood City

Redwood City

Stage

Later Stage

Amount

Investors

$200,000,000 Undisclosed firm

Description

Clinical research services

Later Stage

Kenson Ventures, Morningside Technologies, New Leaf Venture Cell and tissue-based $22,000,000 Partners, Summit Partners diagnostic tests

Expansion

Alloy Ventures, Covidien Ventures, Delphi Ventures, $36,000,000 undisclosed firm

Manufactures surgical and medical instruments

Later Stage

Aberdare Ventures, Edmond de Rothschild Investment Partners SAS, Forbion Capital Partners, InterWest Partners, Kleiner Perkins Caufield & Byers, Novartis Venture Funds, $43,199,800 undisclosed firm

Miniaturized implantable neurostimulation device

Early Stage

Canaan Partners, Deerfield Management Company, Tekla Healthcare Investors, undisclosed firms, Venrock, Wellington Management $70,000,100 Company

Biotechnology company

CytomX Therapeutics

South San Francisco

Denali Therapeutics*

South San Francisco

Early Stage

First Aid Shot Therapy

Burlingame

Expansion

Arch Venture Partners, Fidelity Biosciences, Flagship Ventures, $217,000,000 undisclosed firm Biotechnology company

$20,332,000 Sofinnova Ventures

Page 1 of 11

Consumer healthcare company


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.